Royalty Pharma (RPRX)
undefined
undefined%
At close: undefined
26.10
1.40%
After-hours Jan 06, 2025, 05:05 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio 11.08 404.10 34.53 37.95 6.93 11.44 13.03 47.73 46.46
PS Ratio 5.34 7.74 7.22 8.86 8.97 8.78 9.86 14.39 16.35
PB Ratio 1.93 3.08 2.86 1.90 2.67 3.51 3.53 6.08 5.78
P/FCF Ratio 4.21 4.14 8.19 4.44 -301.24 8.35 -18.07 n/a n/a
P/OCF Ratio 4.21 8.07 8.19 9.24 9.77 9.74 11.11 n/a n/a
OCF/S Ratio 1.27 0.96 0.88 0.96 0.92 0.90 0.89 n/a n/a
Debt / Equity Ratio 0.94 1.26 1.23 0.59 1.02 1.45 1.52 1.33 1.28
Quick Ratio 7.90 2.19 16.81 6.63 2.50 4.46 7.69 10.10 9.68
Current Ratio 7.90 2.19 16.81 8.76 2.50 4.50 7.69 10.10 9.68
Asset Turnover 0.14 0.13 0.13 0.10 0.15 0.16 0.14 0.18 0.15
Interest Coverage 7.97 5.20 8.61 10.16 9.77 4.87 3.80 3.03 3.54
Return on Equity (ROE) 0.17 0.01 0.08 0.05 0.38 0.31 0.27 0.13 0.12
Return on Assets (ROA) 0.07 0.00 0.03 0.02 0.19 0.12 0.11 0.05 0.05
Return on Capital (ROIC) 0.09 0.06 0.08 0.08 0.22 0.13 0.09 0.07 0.08
Dividend Yield 0.03 0.02 0.02 0.02 0.05 0.05 0.05 n/a n/a
Payout Ratio 0.32 7.78 0.60 0.80 0.31 0.59 0.61 n/a n/a
Gross Profit Margin 76.19% 99.75% 99.00% 95.85% 43.82% 92.43% 97.92% 1.00% 1.00%
Net Profit Margin 48.20% 1.91% 20.91% 23.34% 129.45% 76.76% 75.72% 0.30% 0.35%
Pretax Profit Margin 72.20% 10.28% 54.21% 80.21% 135.67% 84.57% 84.06% 0.41% 0.46%
Operating Profit Margin 63.37% 43.69% 62.49% 75.16% 144.59% 76.02% 58.81% 0.39% 0.48%
FCF Margin 126.89% 187.07% 88.15% 199.42% -2.98% 105.18% -54.6% n/a n/a
EBITDA Margin 80.15% 41.51% 63.50% 79.34% 145.91% 77.87% 60.89% n/a n/a